Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction

JAMA Cardiology

Volumn 1, Issue 5, 2016, Pages 510-518

  Kalogeropoulos, Andreas P ^a   Fonarow, Gregg C ^b   Georgiopoulou, Vasiliki ^a   Burkman, Gregory ^a   Siwamogsatham, Sarawut ^a,c   Patel, Akash ^e   Li, Song ^e   Papadimitriou, Lampros ^a,d   Butler, Javed ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d STONY BROOK UNIVERSITY   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION COST; HUMAN; HUMAN CHARACTERISTIC; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; PROGNOSIS; STATISTICS AND NUMERICAL DATA;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; OUTPATIENTS; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 85011633843     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.1325     Document Type: Article

References (30)

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251-259.
2. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296(18):2209-2216.
3. Gurwitz JH, Magid DJ, Smith DH, et al. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013;126(5):393-400.
4. Berry C, Hogg K, Norrie J, Stevenson K, Brett M, McMurray J. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart. 2005;91(7):907-913.
5. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355 (3):260-269.
6. Gheorghiade M, Abraham WT, Albert NM, et al; OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296(18):2217-2226.
7. Steinberg BA, Zhao X, Heidenreich PA, et al; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012;126(1):65-75.
8. Katz DH, Beussink L, Sauer AJ, Freed BH, Burke MA, Shah SJ. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. Am J Cardiol. 2013;112(8):1158-1164.
9. Kitzman DW, Upadhya B. Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology. J Am Coll Cardiol. 2014;63(5):457-459.
10. Shah AM, Shah SJ, Anand IS, et al; TOPCAT Investigators. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist trial. Circ Heart Fail. 2014;7(1):104-115.
11. Yancy CW, Jessup M, Bozkurt B, et al;Writing Committee Members; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16): e240-e327. doi:10.1161/CIR.0b013e31829e8776.
12. Punnoose LR, Givertz MM, Lewis EF, Pratibhu P, Stevenson LW, Desai AS. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail. 2011;17(7):527-532.
13. Basuray A, French B, Ky B, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014;129(23):2380-2387.
14. Centers for Medicare & Medicaid Services. Heart failure (HF): algorithm for measures calculation: EHRS. http://www.cms.gov/Medicare/Demonstration-Projects/DemoProjectsEvalRpts/Downloads/MMA649-HF-EHRS-Algorithm.pdf. Accessed July 14, 2015.
15. Centers for Medicare & Medicaid Services. Chronic Conditions Data Warehouse: condition categories. https://www.ccwdata.org/web/guest/condition-categories. Accessed July 3, 2015.
16. Healthcare Cost and Utilization Project (HCUP). HCUP Clinical Classifications Software (CCS) for ICD-9-CM. http://hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed May 24, 2016.
17. Rogers JK, McMurray JJ, Pocock SJ, et al. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations. Circulation. 2012;126(19):2317-2323.
18. Psaty BM, Shah SJ, Gottdiener J. Letter by Psaty et al regarding article, "Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes." Circulation. 2015;131(6): e343. doi:10.1161/CIRCULATIONAHA.114.012243.
19. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation. 2006;113 (2):266-272.
20. Zecchin M, Merlo M, Pivetta A, et al. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?" Am J Cardiol. 2012;109(5):729-735.
21. de Groote P, Fertin M, Duva Pentiah A, Goéminne C, Lamblin N, Bauters C. Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy. Circ Heart Fail. 2014;7(3):434-439.
22. Wilcox JE, Fonarow GC, Yancy CW, et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012;163 (1):49-56.e2. doi:10.1016/j.ahj.2011.10.001.
23. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function: the Cardiovascular Health Study. Ann Intern Med. 2002;137(8):631-639.
24. Ramahi TM, Longo MD, Cadariu AR, et al. Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after β-blocker therapy in nonischemic cardiomyopathy. J AmColl Cardiol. 2001;37(3): 818-824.
25. 2C-adrenergic receptors and the influence on left ventricular ejection fraction response to β-blocker therapy in heart failure. Pharmacogenet Genomics. 2007;17 (4):277-282.
26. Levine TB, Levine AB, Bolenbaugh J, Stomel RJ. Impact of left ventricular size on pharmacologic reverse remodeling in heart failure. Clin Cardiol. 2000;23(5):355-358.
27. Cicoira M, Zanolla L, Rossi A, et al. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J AmColl Cardiol. 2001;37(7):1808-1812.
28. Kutyifa V, Kloppe A, Zareba W, et al. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J AmColl Cardiol. 2013;61(9):936-944.
29. Pezzali N, Curnis A, Specchia C, et al. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results. Europace. 2013;15(10):1475-1481.
30. Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail. 2012;5 (6):720-726.